Xu Q - Search Results

1

Evaluation of glioma-associated oncogene 1 expression and its correlation with the expression of sonic hedgehog, E-cadherin and S100a4 in human hepatocellular carcinoma.

Zheng X, Yao Y, Xu Q, Tu K, Liu Q. Zheng X, et al. Among authors: xu q. Mol Med Rep. 2010 Nov-Dec;3(6):965-70. doi: 10.3892/mmr.2010.375. Epub 2010 Sep 27. Mol Med Rep. 2010. PMID: 21472341

2

[Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma].

Xu QR, Zheng X, Zan XF, Yao YM, Yang W, Liu QG. Xu QR, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 May;28(5):536-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012. PMID: 22558994 Chinese.

3

Role of the Hedgehog pathway in hepatocellular carcinoma (review).

Zheng X, Zeng W, Gai X, Xu Q, Li C, Liang Z, Tuo H, Liu Q. Zheng X, et al. Among authors: xu q. Oncol Rep. 2013 Nov;30(5):2020-6. doi: 10.3892/or.2013.2690. Epub 2013 Aug 22. Oncol Rep. 2013. PMID: 23970376 Review.

4

AMPK regulates histone H2B O-GlcNAcylation.

Xu Q, Yang C, Du Y, Chen Y, Liu H, Deng M, Zhang H, Zhang L, Liu T, Liu Q, Wang L, Lou Z, Pei H. Xu Q, et al. Nucleic Acids Res. 2014 May;42(9):5594-604. doi: 10.1093/nar/gku236. Epub 2014 Apr 1. Nucleic Acids Res. 2014. PMID: 24692660 Free PMC article.

5

The transcriptional activity of Gli1 is negatively regulated by AMPK through Hedgehog partial agonism in hepatocellular carcinoma.

Xu Q, Liu X, Zheng X, Yao Y, Wang M, Liu Q. Xu Q, et al. Int J Mol Med. 2014 Sep;34(3):733-41. doi: 10.3892/ijmm.2014.1847. Epub 2014 Jul 10. Int J Mol Med. 2014. PMID: 25017332 Free PMC article.

6

PKM2 regulates Gli1 expression in hepatocellular carcinoma.

Xu Q, Liu X, Zheng X, Yao Y, Liu Q. Xu Q, et al. Oncol Lett. 2014 Nov;8(5):1973-1979. doi: 10.3892/ol.2014.2441. Epub 2014 Aug 12. Oncol Lett. 2014. PMID: 25289083 Free PMC article.

7

[The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].

Xu Q, Cai W, Zhang M, Liu Q, Liu X. Xu Q, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Mar;32(3):387-92. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016. PMID: 26927562 Chinese.

8

TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.

Ye S, Zhao XY, Hu XG, Li T, Xu QR, Yang HM, Huang DS, Yang L. Ye S, et al. Oncol Rep. 2017 Apr;37(4):2215-2226. doi: 10.3892/or.2017.5494. Epub 2017 Mar 8. Oncol Rep. 2017. PMID: 28350084 Free PMC article.

9

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.

Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K. Xu Q, et al. Mol Cancer. 2017 Jun 12;16(1):103. doi: 10.1186/s12943-017-0675-y. Mol Cancer. 2017. PMID: 28606154 Free PMC article.

10

microRNA-526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma.

Liu X, Yang L, Tu J, Cai W, Zhang M, Shou Z, Yao Y, Xu Q. Liu X, et al. Among authors: xu q. Oncotarget. 2017 Sep 23;8(50):87737-87749. doi: 10.18632/oncotarget.21209. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152116 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,246 results

Search Page

Filters